Detection of soluble HLA-G molecules in plasma and amniotic fluid

Tissue Antigens

Volumn 53, Issue 1, 1999, Pages 14-22

  Rebmann, V ^a   Pfeiffer, K ^b   Passler M ^a   Ferrone, S ^c   Maier, S ^d   Weiss, E ^d   Grosse Wilde, Hans ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b UNIVERSITY OF BONN   (Germany)

^c NEW YORK MEDICAL COLLEGE   (United States)

^d UNIVERSITY OF MUNICH   (Germany)

Author keywords

Alternative splicing products of HLA G; Isoforms of sHLA G; Native soluble HLA G; Soluble HLA class I

Indexed keywords

EDETIC ACID; HLA A ANTIGEN; HLA ANTIGEN CLASS 1; HLA G ANTIGEN; MONOCLONAL ANTIBODY;

AMNION FLUID; ARTICLE; DELIVERY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; MALE; NORMAL HUMAN; PLASMA; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; UMBILICAL CORD BLOOD;

ADULT; AMNIOTIC FLUID; ANIMALS; ANTIBODIES, MONOCLONAL; BETA 2-MICROGLOBULIN; BLOOD PROTEIN ELECTROPHORESIS; CELL LINE; CHORIOCARCINOMA; CROSS REACTIONS; CULTURE MEDIA, SERUM-FREE; DROSOPHILA MELANOGASTER; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FETAL BLOOD; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA ANTIGENS; HUMANS; IMMUNOMAGNETIC SEPARATION; INFANT, NEWBORN; K562 CELLS; MALE; MOLECULAR WEIGHT; PLASMA; PREGNANCY; RNA SPLICING; SENSITIVITY AND SPECIFICITY; SEX CHARACTERISTICS; SOLUBILITY; TRANSFECTION; TUMOR CELLS, CULTURED; UTERINE NEOPLASMS;

EID: 0033004580     PISSN: 00012815     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-0039.1999.530102.x     Document Type: Article

References (46)

1. 1. Alizadeh M, Legras C, Semana G, Le Bouteiller P, Genetet B, Fauchet R. Evidence for a polymorphism of HLA-G gene. Hum Immunol 1993: 38: 206-12.
2. 2. Morales P, Corell A, Martinez-Laso J et al. Three new HLA-G alleles and their linkage disequilibria with HLA-A. Immunogenetics 1993: 38: 323-31.
3. 3. Van der Ven K, Ober C. HLA-G polymorphisms in African Americans. J Immunol 1994: 153: 5628-33.
4. 4. Kovats S, Main EK, Librach C, Stubblebine M, Fisher SJ, DeMars R. A class I antigen, HLA-G, expressed in human trophoblasts. Science 1990: 248: 220-3.
5. 5. McMaster MT, Librach CL, Zhou Y et al. Human placental HLA-G expression is restricted to differentiated cytotrophoblasts. J Immunol 1995: 154: 3771-8.
6. 6. Kirszenbaum M, Moreau P, Gluckman E, Dausset J, Carosella E. An alternatively spliced form of HLA-G mRNA in human trophoblasts and evidence for the presence of HLA-G transcript in adult lymphocytes. Proc Natl Acad Sci U S A 1994: 91: 4209-13.
7. 7. Ishitani A, Geraghty DE. Alternative splicing of HLA-G transcripts yields proteins with primary structures resembling both class I and class II antigens. Proc Natl Acad Sci U S A 1992: 89: 3947-51.
8. 8. Shukla H, Swaroop A, Srivastava R, Weissmann SM. The mRNA of a human class I gene HLA-G/HLA 6.0 exhibits a restricted pattern of expression. Nucleic Acids Res 1990: 18: 2189-92.
9. 9. Houlihan JM, Fergar-Payne A, Biro PA, Simpson KL, Holmes CH. Evidence for expression of non-HLA-A, -B, -C class I genes in human fetal liver. J Immunol 1992: 149: 668-72.
10. 10. Ulbrecht M, Rehberger B, Stroebel I et al. HLA-G: expression in human keratinocytes in vitro and in human skin in vivo. Eur J Immunol 1994: 24: 176-80.
11. 11. Sanders SK, Giblin PA, Kavathas P. Cell-cell adhesion mediated by CD8 and human histocompatibility leukocyte antigen G, a nonclassical major histocompatibility complex class I molecule on cytotrophoblasts. J Exp Med 1991: 174: 737-40.
12. 12. Münz C, Holmes N, King A et al. Human histocompatibility leukocyte antigen (HLA)-G molecules inhibit NKAT3 expressing natural killer cells. J Exp Med 1997: 185: 385-91.
13. 13. Fujii T, Ishitani A, Geragthy DE. A soluble form of the HLA-G antigen is encoded by a messenger ribonucleic acid containing intron 4. J Immunol 1994: 153: 5516-24.
14. 14. Krangel MS. Secretion of HLA-A and -B antigens via an alternative RNA splicing pathway. J Exp Med 1986: 163: 1173-90.
15. 15. Sernee MF, Ploegh HL, Schust DJ. Why certain antibodies cross-react with HLA-A and HLA-G: Epitope mapping of two common MHC class I reagents. Mol Immunol 1998: 35: 177-88.
16. 16. Burt D, Johnston D, Rinke de Wit T, van den Elsen P, Stern PL. Cellular immune recognition of HLA-G-expressing chorioncarcinoma cell line JEG3. Int J Cancer 1991: 6: 117-22.
17. 17. Grosse-Wilde H, Ferrara GB. European collection for biomedical research. Eur J Immunogenetics 1992: 19: 190-232.
18. 18. Ulbrecht M, Modrow S, Srivastava R, Peterson PA, Weiss EH. Interaction of HLA-E with peptides and the peptide transporter in vitro: Implications for its function in antigen presentation. J Immunol 1998: 160: 4375-85.
19. 19. Tanabe M, Sekimata M, Ferrone S, Takiguchi M. Structural and functional analysis of monomorphic determinants recognised by monoclonal antibodies reacting with the HLA class I α3 domain. J Immunol 1992: 148: 3202-09.
20. 20. Lee N, Malacko AR, Ishitani A et al. The membrane-bound and soluble forms of HLA-G bind identical sets of endogenous peptides but differ with respect to TAP association. Immunity 1995: 3: 591-600.
21. 21. Neefjes JJ, Doxiadis I, Stam NJ, Beckers CJ, Ploegh HL. An analysis of class I antigens of man and other species by one-dimensional IEF and immunoblotting. Immunogenetics 1986: 23: 164-9.
22. 22. Westhoff U, Grosse-Wilde H. Soluble HLA class I and class II concentrations in factor VIII and PCC preparations. Vox Sang 1995: 68: 73-6.
23. 23. Pouletty P, Ferrone S, Amesland F et al. Summary report from the first international workshop on soluble HLA antigens. Paris, August 1992. Tissue Antigens 1993: 42: 45-54.
24. 24. Kubens BS, Päßler M, Grosse-Wilde H. Segregation study of the soluble 39-kD HLA class I heavy chain. Hum Immunol 1994: 40: 247-52.
25. 25. Moreau P, Carosella E, Teyssier M et al. Soluble HLA-G molecule. An alternatively spliced HLA-G mRNA form candidate to encode it in peripheral blood mononuclear cells and human trophoblasts. Hum Immunol 1995: 43: 231-6.
26. 26. Pollard SG, Davies HF, Calne RY. Peroperative appearance of serum class I antigen during liver transplantation. Transplantation 1990: 49: 428-30.
27. 27. Onno M, Guillaudeux T, Amiot L et al. HLA-G gene is expressed at a low mRNA level in different human cells and tissues. Hum Immunol 1994: 41: 79-86.
28. 28. Dobbe LME, Stam JF, Neefjes JJ, Giphart MJ. Biochemical complexity of serum HLA class I molecules. Immunogenetics 1988: 27: 203-10.
29. 29. Amiot L, Drénou B, Onno M et al. HLA-G surface expression in haematopoietic cells using a new monoclonal antibody BFL1. In: Charron D, ed. Genetic diversity of HLA. Vol 2. Sèvres, France: EDK International Publisher, 1997: 239-41.
30. 30. Gail T, Colbern DVM, Chiang MH, Main EK. Expression of nonclassic histocompatibility antigen HLA-G by preeclamptic placenta. Am J Obstet Gynecol 1994: 170: 1244-50.
31. 31. Schmidt CM, Orr HT. Maternal/fetal interactions: The role of the MHC class I molecule HLA-G. Crit Rev Immunol 1993: 13: 207-24.
32. 32. Wegmann TG, Lin H, Guilbert L, Mosmann TR. Bidirectional cytokine interactions in the maternal-fetal relationship: Is successful pregnancy a TH2 phenomenon? Immunol Today 1993: 14: 353-6.
33. 33. Ober C, Aldrich C, Rosinsky B et al. HLA-G1 protein expression is not essential for fetal survival. Placenta 1998: 19: 127-32.
34. 34. Inostroza J, Ferrada J, Navarrete C, Sorensen RU. Soluble histocompatibility class I antigens and β2 microglobulin in pregnant females and cord blod samples. Hum Immunol 1997: 54: 63-8.
35. 35. Houlihan JM, Biro PA, Harper HM, Jenkinson HJ, Holmes CH. The human amnion is a site of MHC class Ib expression: Evidence for the expression of HLA-E and HLA-G. J Immunol 1995: 154: 5665-74.
36. 36. Hammer A, Hutter H, Blaschitz A et al. Amnion epithelial cells, in contrast to trophoblast cells, express all classical HLA class I molecules together with HLA-G. Am J Reprod Immunol 1997: 37: 161-71.
37. 37. McMaster M, Zhou Y, Shorter S et al. HLA-G isoforms produced by placental cytotrophoblasts and found in amniotic fluid are due to unsual glycosylation. J Immunol 1998: 160: 5922-8.
38. 38. Karhukorpi J, Ikäheimo I, Silvennoinen-Kassinen S, Tiilikainen A. HLA-G polymorphism and allelic association with HLA-A in a Finnish population. Eur J Immunogenetics 1996: 23: 153-5.
39. 39. Singer DS, Maguire JE. Regulation of the expression of class I MHC genes. Crit Rev Immunol 1990: 10: 235-57.
40. 40. Yang Y, Chu W, Geraghty DE, Hunt JS. Expression of HLA-G in human mononuclear phagocytes and selective induction by IFN-γ. J Immunol 1996: 156: 4224-31.
41. 41. Diehl M, Münz C, Keilholz W et al. Nonclassical HLA-G molecules are classical peptide presenters. Current Biology 1996: 6: 305-14.
42. 42. Schust DJ, Tortorella D, Seebach J, Phan C, Ploeg HL. Trophoblast class I major histocompatibility complex (MHC) products are resistant to rapid degradation imposed by the human cytomegalovirus (HCMV) gene products US2 and US11. J Exp Med 1998: 188: 497-503.
43. 43. Pende D, Sivori S, Accame L et al. HLA-G recognition by human natural killer cells. Involvement of CD94 both as inhibitory and as activating receptor complex. Eur J Immunol 1997: 27: 1875-80.
44. 44. Perez-Villar JJ, Melero I, Navarro F et al. The CD94/NKG2-A inhibitory receptor complex is involved in natural killer cell-mediated recognition of cells expressing HLA-G1. J Immunol 1997: 158: 5736-43.
45. 45. Borrego F, Ulbrecht M, Weiss EH, Coligan JE, Brooks AG. Recognition of human histocompatibility leukocyte antigen (HLA)-E complexed with HLA class I signal sequence-derived peptides by CD94/ NKG2 confers protection from natural killer cell-mediated lysis. J Exp Med 1998: 187: 813-18.
46. 46. Braud VM, Allan DS, O'Callaghan CA et al. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C. Nature 1998: 391: 795-9.